Skip to main content
SpringerLink
Log in

Basal Cell Carcinoma

  • Chapter
Managing Skin Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hayes RC, Leonfellner S, Pilgrim W, Liu J, Keeling DN (2007) Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg 11:45 –52

    PubMed  Google Scholar 

  2. Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C (1994) The emerging epidemic of skin cancer. Br J Dermatol 130:269 –272

    Article  PubMed  CAS  Google Scholar 

  3. Marks R, Staples M, Giles GG (1993) Trends in non-mel-anocytic skin cancer treated in Australia: the second national survey. Int J Cancer 53:585 –590

    Article  PubMed  CAS  Google Scholar 

  4. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774 –778

    Article  PubMed  CAS  Google Scholar 

  5. Gilbody JS, Aitken J, Green A (1994) What causes basal cell carcinoma to be the commonest cancer? Aust J Public Health 18:218 –221

    Article  PubMed  CAS  Google Scholar 

  6. Miller SJ (1991) Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24:1 –13

    Article  PubMed  CAS  Google Scholar 

  7. Stern R (2007) The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 135:843 –844

    Article  Google Scholar 

  8. American Cancer Society Facts and Figures. American Cancer Society. 1 –1 –2008

    Google Scholar 

  9. Lear W, Dahlke E, Murray CA (2007) Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 11:19 –30

    PubMed  Google Scholar 

  10. Scrivener Y, Grosshans E, Cribier B (2002) Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147:41 –47

    Article  PubMed  CAS  Google Scholar 

  11. Mikhail GR, Nims LP, Kelly AP Jr, Ditmars DM Jr, Eyler WR (1977) Metastatic basal cell carcinoma: review, pathogenesis, and report of two cases. Arch Dermatol 113:1261 –1269

    Article  PubMed  CAS  Google Scholar 

  12. von DH, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10:1043 –1060

    Article  PubMed  Google Scholar 

  13. Affleck AG, Gore A, Millard LG, Perks, AGD, Kulkarni K, Chan S (2007) Giant primary basal cell carcinoma with fatal hepatic metastases. JEADV 21:262 –263

    PubMed  CAS  Google Scholar 

  14. Lo JS, Sow SN, Reizner GT, et al (1991) Metastic basal cell carcinoma: a report of twelve cases with a review of the literature. J Am Acad Dermatol 24:715 –718

    Article  PubMed  CAS  Google Scholar 

  15. Robinson, JK, Dahiya M (2003) Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 139:643 –648

    Article  Google Scholar 

  16. Sahl WJ, Snow SN, Levine NS (1994) Giant basal cell carcinoma. Report of two cases and review of the literature. J Am Acad Dermatol 30:856 –859

    Article  Google Scholar 

  17. Fears TR, Scotto J, Schneiderman MA (1977) Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 105:420 –427

    PubMed  CAS  Google Scholar 

  18. Harris RB, Griffith K, Moon TE (2001) Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985 –1996. J Am Acad Dermatol 45:528 –536

    Article  PubMed  CAS  Google Scholar 

  19. Hoy WE (1996) Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 77:2489 –2495

    Article  PubMed  CAS  Google Scholar 

  20. Marshall DR (1968) The clinical and pathological effects of prolonged solar exposure. II: the association with basal cell carcinoma. Aust N Z J Surg 38:89 –97

    PubMed  CAS  Google Scholar 

  21. Oettle AG (1963) Skin cancer in Africa. Natl Cancer Inst Monogr 10:197

    Google Scholar 

  22. Quisenberry WB (1963) Ethnic difference in skin cancer in Hawaii. Natl Cancer Inst Monogr 10:181

    Google Scholar 

  23. Ten Seldam REJ (1963) Skin cancer in Australia. Natl Cancer Inst Monogr 10:153

    Google Scholar 

  24. Vitaliano PP, Urbach F (1980) The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol 16:454 –456

    Article  Google Scholar 

  25. Alexander GA, Henschke UK (1981) Advanced skin cancer in Tanzanian albinos: preliminary observations. J Natl Med Assoc 73:1047 –1054

    PubMed  CAS  Google Scholar 

  26. Keeler EE (1963) Albinism, zeroderma pigmentosum and skin cancer. Natl Cancer Inst Monogr 10:349

    Google Scholar 

  27. Okoro AN (1975) Albinism in Nigeria. A clinical and social study. Br J Dermatol 92:485 –492

    Article  PubMed  CAS  Google Scholar 

  28. Beckenstein MS, Windle BH (1995) Basal cell carcinoma in black patients: the need to include it in the differential diagnosis. Ann Plast Surg 35:546 –548

    Article  PubMed  CAS  Google Scholar 

  29. Fleming ID, Barnwell JR, Burleson PE, et al (1975) Skin cancer in black patients. Cancer 35:600 –605

    Article  PubMed  CAS  Google Scholar 

  30. Mora RG, Burris R (1981) Cancer of the skin in blacks: a review of 128 patients with basal-cell carcinoma. Cancer 47:1436 –1438

    Article  PubMed  CAS  Google Scholar 

  31. Fears TR, Scotto J (1983) Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure. Cancer Invest 1:119 –126

    Article  PubMed  CAS  Google Scholar 

  32. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216 –4220

    Article  PubMed  CAS  Google Scholar 

  33. Kripke ML (1983) The effect of ultraviolet radiation on the immune system. In: Parrish JA (ed) A scientific round table. Johnson and Johnson Baby Products, New Brunswick, NJ, pp 87 –106

    Google Scholar 

  34. Daynes RA, Bernhard EJ, Gurish MF, Lynch DH (1981) Experimental photoimmunology: immunologic ramifications of UV-induced carcinogenesis. J Invest Dermatol 77:77 –85

    Article  PubMed  CAS  Google Scholar 

  35. Gurish MF, Roberts LK, Krueger GG, Daynes RA (1981) The effect of various sunscreen agents on skin damage and the induction of tumor susceptibility in mice subjected to ultraviolet irradiation. J Invest Dermatol 76:246 –251

    Article  PubMed  CAS  Google Scholar 

  36. Kripke ML (1982) The role of UVR-induced immunosup-pression in experimental photocarcinogenesis. Progr Derm 16:1

    Google Scholar 

  37. Kripke ML (1977) Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res 37:1395 –1400

    PubMed  CAS  Google Scholar 

  38. Kripke ML (1977) Ultraviolet radiation and tumor immunity. J Reticuloendothel Soc 22:217 –222

    PubMed  CAS  Google Scholar 

  39. Kripke ML (1981) Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34:69 –106

    Article  PubMed  CAS  Google Scholar 

  40. Kripke ML (1974) Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 53:1333 –1336

    PubMed  CAS  Google Scholar 

  41. Kripke ML, Morison WL, Parrish JA (1981) Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus U VA radiation. J Invest Dermatol 76:445 –448

    Article  PubMed  CAS  Google Scholar 

  42. Toews GB, Bergstresser PR, Streilein JW (1980) Epidermal langerhans cell density determines whether contact hyper-sensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124:445–453

    PubMed  CAS  Google Scholar 

  43. Zelickson AS, Mottaz J (1970) The effect of sunlight on human epidermis. A quantitative electron microscopic study of dendritic cells. Arch Dermatol 101:312–315

    Article  PubMed  CAS  Google Scholar 

  44. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK (1992) p53 mutations in basal cell carcinomas. Cancer Res 52:3804–3806

    PubMed  CAS  Google Scholar 

  45. Dicker T, Siller G, Saunders N (2002) Molecular and cellular biology of basal cell carcinoma. Australas J Dermatol 43:241–246

    Article  PubMed  Google Scholar 

  46. Ouhtit A, Nakazawa H, Armstrong BK, Kricker A, Tan E, Yamasaki H, English DR (1998) UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst 90:523–531

    Article  PubMed  CAS  Google Scholar 

  47. Cleaver JE (1969) Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci USA 63:428–435

    Article  PubMed  CAS  Google Scholar 

  48. Cleaver JE (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature 218:652–656

    Article  PubMed  CAS  Google Scholar 

  49. Kraemer KH (1981) Cancer prone genodermatoses and DNA repair. Progr Derm 15:1

    Google Scholar 

  50. Lehmann AR, Kirk-Bell S, Arlett CF, Harcourt SA, de Weerd-Kastelein EA, Keijzer W, Hall-Smith P (1977) Repair of ultraviolet light damage in a variety of human fibroblast cell strains. Cancer Res 37:904–910

    PubMed  CAS  Google Scholar 

  51. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, Toftgard R (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78–81

    Article  PubMed  CAS  Google Scholar 

  52. ya-Grosjean L, Couve-Privat S (2005) Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 225:181–192

    Article  CAS  Google Scholar 

  53. Lacour JP (2002) Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 146(Suppl 61):17–19

    Article  PubMed  CAS  Google Scholar 

  54. Kim MY, Park HJ, Baek SC, Byun DG, Houh D (2002) Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 29:1–9

    Article  PubMed  Google Scholar 

  55. Czarnecki D, Tait B, Nicholson I, Lewis A (1994) Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers. Dermatology 188:88–90

    Article  PubMed  CAS  Google Scholar 

  56. Kennedy C, Bajdik CD, Willemze R, Bouwes Bavinck JN (2005) Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin. Br J Dermatol 152:194–197

    Article  PubMed  CAS  Google Scholar 

  57. Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A (2004) Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg 30:248–252

    Article  Google Scholar 

  58. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP (1990) Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49:506–509

    Article  PubMed  CAS  Google Scholar 

  59. Jensen P, Moller B, Hansen S (2000) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 42:307

    Article  PubMed  CAS  Google Scholar 

  60. Webb MC, Compton F, Andrews PA, Koffman CG (1997) Skin tumours posttransplantation: a retrospective analysis of 28 years ' experience at a single centre. Transplant Proc 29:828 –830

    Article  PubMed  CAS  Google Scholar 

  61. Kraemer KH, Lee MM, Andrews AD, Lambert WC (1994) The role of sunlight and DNA repair in melanoma and non-melanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130:1018–1021

    Article  PubMed  CAS  Google Scholar 

  62. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513–519

    PubMed  CAS  Google Scholar 

  63. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Hartland AJ, Whiteside JR, Jones PW, Strange RC (2001) Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. Pharmacogenetics 11:247–254

    Article  PubMed  CAS  Google Scholar 

  64. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L (1995) DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol 104:933–936

    Article  PubMed  CAS  Google Scholar 

  65. (1994) Guidelines of care for phototherapy and photochemo-therapy. American academy of dermatology committee on guidelines of care. J Am Acad Dermatol 31:643–648

    Google Scholar 

  66. Lear JT, Heagerty AH, Smith A, Bowers B, Payne CR, Smith CA, Jones PW, Gilford J, Yengi L, Alldersea J, Fryer AA, Strange RC (1996) Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis 17:1891–1896

    Article  PubMed  CAS  Google Scholar 

  67. Freeman RG, Duncan C (1973) Recurrent skin cancer. Arch Dermatol 107:395–399

    Article  PubMed  CAS  Google Scholar 

  68. Popkin GL, Bart RS (1975) Excision versus curettage and electrodesiccation as dermatologic office procedures for the treatment of basal-cell carcinomas. J Dermatol Surg 1:33–35

    PubMed  CAS  Google Scholar 

  69. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Michalski J, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ, Urist MM (2007) Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 5:506–529

    PubMed  Google Scholar 

  70. Lang PG, Maize JC (2005) Basal Cell Carcinoma. In: Rigel DS, Friedman RJ, Dzubow LM, Reintgen DS, Bystryn JC, Marks R (eds) Cancer of the skin. Elsevier Saunders, Philadelphia

    Google Scholar 

  71. Spiller WF, Spiller RF (1984) Treatment of basal cell epithe-lioma by curettage and electrodesiccation. J Am Acad Dermatol 11:808–814

    Article  PubMed  CAS  Google Scholar 

  72. Swanson NA (1983) Mohs surgery: technique, indications, applications, and the future. Archives of Dermatology 119:761–773

    Article  PubMed  CAS  Google Scholar 

  73. Sweet RD (1983) The management of basal cell carcinoma by curettage. Br J Dermatol 75:137–148

    Article  Google Scholar 

  74. Knox J, Lyles TW, Shapiro EM, et al (1960) Curettage and electrodesiccation in the treatment of skin cancer. Arch Dermatol 82:197

    Article  PubMed  CAS  Google Scholar 

  75. KNOX JM, Freeman RG, HEATON CL (1962) Curettage and electrodesiccation in the treatment of skin cancer. South Med J 55:1212 –1215

    Article  PubMed  CAS  Google Scholar 

  76. Sloane JP (1977) The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 96:127–132

    Article  PubMed  CAS  Google Scholar 

  77. Kopf AW, Bart RS, Schrager D, Lazar M, Popkin GL (1977) Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 113:439–443

    Article  PubMed  CAS  Google Scholar 

  78. Tromovitch TA (1965) Skin cancer; treatment by curettage and desiccation. Calif Med 103:107–108

    PubMed  CAS  Google Scholar 

  79. McDaniel WE (1978) Surgical therapy for basal cell epithe-liomas by curettage only. Arch Dermatol 114:1491–1492

    Article  PubMed  CAS  Google Scholar 

  80. McDaniel WE (1983) Therapy for basal cell epitheliomas by curettage only. Further study. Arch Dermatol 119:901–903

    Article  PubMed  CAS  Google Scholar 

  81. Reymann F (1975) Multiple basal cell carcinomas of the skin. Treatment with curettage. Arch Dermatol 111:877–879

    Article  PubMed  CAS  Google Scholar 

  82. Reymann F (1971) Treatment of basal cell carcinoma of the skin with curettage. Arch Dermatol 103:623–627

    Article  PubMed  CAS  Google Scholar 

  83. Thissen MR, Neumann MH, Schouten LJ (1999) A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135:1177–1183

    Article  PubMed  CAS  Google Scholar 

  84. Bisson MA, Dunkin CS, Suvarna SK, Griffiths RW (2002) Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins. Br J Plast Surg 55:293–297

    Article  PubMed  CAS  Google Scholar 

  85. Burg G, Hirsch RD, Konz B, Braun-Falco O (1975) Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg 1:21–24

    PubMed  CAS  Google Scholar 

  86. Epstein E (1973) How accurate is the visual assessment of basal carcinoma margins? Br J Dermatol 89:37–43

    Article  PubMed  CAS  Google Scholar 

  87. Hudson-Peacock MJ, Matthews JN, Lawrence CM (1995) Relation between size of skin excision, wound, and specimen. J Am Acad Dermatol 32:1010–1015

    Article  Google Scholar 

  88. Richmond JD, Davie RM (1987) The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 40:63–67

    Article  PubMed  CAS  Google Scholar 

  89. Roenigk RK, Ratz JL, Bailin PL, Wheeland RG (1986) Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 12:860–865

    PubMed  CAS  Google Scholar 

  90. Ceilley RI, Del Rosso JQ (2006) Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 45:489–498

    Article  PubMed  Google Scholar 

  91. Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ (1992) Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 18:549–554

    PubMed  CAS  Google Scholar 

  92. Hunter RD (1985) The radiotherapy of malignant disease. 1st edition, In: Easson EC, Pointon RCS (eds) Skin. Springer, New York, NY, pp 135

    Google Scholar 

  93. Dubin N, Kopf AW (1983) Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 119:373–377

    Article  PubMed  CAS  Google Scholar 

  94. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, Kaufmann R, de RM, Legat FJ, Stender IM, Soler AM, Wennberg AM, Wong GA, Larko O (2003) Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149:1242–1249

    Article  PubMed  CAS  Google Scholar 

  95. Vinciullo C, Eliott T, Gebauer K, Spelman L, Ngyen R (2004) MAL-PDT in patients with basal cell carcinoma: results of an Australian multicenter study. International Skin Cancer Conference

    Google Scholar 

  96. Bassett-Seguin, Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M, et al (2004) MAL-PDT versus cryo-therapy in primary sBCC: results of 36 months follow-up. J Eur Acad Dermatol Venereol 18(Suppl 2):412

    Google Scholar 

  97. Bassett-Seguin N, Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M, et al (2005) MAL-PDT vs. cryother-apy in primary sBCC: results of 48 month follow-up. J Eur Acad Dermatol Venereol 19(Suppl 2):237

    Google Scholar 

  98. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, nders-son-Engels S, Svanberg S, Svanberg K (2001) Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144:832–840

    Article  PubMed  CAS  Google Scholar 

  99. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE (2001) Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 15:140–145

    Article  Google Scholar 

  100. Rhodes LE, de RM, Enstrom Y, Groves R, Morken T, Goulden V, Wong GA, Grob JJ, Varma S, Wolf P (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140:17–23

    Article  PubMed  CAS  Google Scholar 

  101. Tope WD, Menter A, El-Azhary RA, Lowe NJ, Jarratt M, Pariser DM, et al (2004) Comparison of topical methyl aminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular BCC. J Eur Acad Dermatol Venereol 18(Suppl 2):13–14

    Google Scholar 

  102. Calzavara-Pinton PG (1995) Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 29:53–57

    Article  Google Scholar 

  103. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, ndersson-Engels S, Berg R, Johansson J, Svanberg S (1994) Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensiti-zation and laser irradiation. Br J Dermatol 130:743–751

    Article  PubMed  CAS  Google Scholar 

  104. Thissen MR, Schroeter CA, Neumann HA (2000) Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 142:338–339

    Article  PubMed  CAS  Google Scholar 

  105. Soler AM, Warloe T, Tausjo J, Berner A (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 79:204–206

    Article  PubMed  CAS  Google Scholar 

  106. Sacchini V, Lovo GF, Arioli N, Nava M, Bandieramonte G (1984) Carbon dioxide laser in scalp tumor surgery. Lasers Surg Med 4:261–269

    Article  PubMed  CAS  Google Scholar 

  107. Wheeland RG, Bailin PL, Ratz JL, Roenigk RK (1987) Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas. J Dermatol Surg Oncol 13:119–125

    PubMed  CAS  Google Scholar 

  108. Iyer S, Bowes L, Kricorian G, Friedli A, Fitzpatrick RE (2004) Treatment of basal cell carcinoma with the pulsed carbon dioxide laser: a retrospective analysis. Dermatol Surg 30:1214–1218

    Article  PubMed  Google Scholar 

  109. Thomas DJ, King AR, Peat BG (2003) Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 112:57–63

    Article  PubMed  Google Scholar 

  110. Walker P, Hill D (2006) Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 47:1–12

    Article  PubMed  Google Scholar 

  111. Wolf DJ, Zitelli JA (1987) Surgical margins for basal cell carcinoma. Arch Dermatol 123:340–344

    Article  PubMed  CAS  Google Scholar 

  112. Marks R, Ainslie J, Bekhor P, Green A, Henderson M, Hill D (2002) Clinical practice guidelines non-melanoma skin cancer: guideline for treatment and management in Australia. 35–47. Commonwealth of Australia, Canberra

    Google Scholar 

  113. Miller SJ (2004) Basal cell and squamous cell skin cancers. Practice Guidelines in Oncology, National Comprehensive Cancer Network

    Google Scholar 

  114. Telfer NR, Colver GB, Bowers PW (1999) Guidelines for the management of basal cell carcinoma. British association of dermatologists. Br J Dermatol 141:415–423

    Article  PubMed  CAS  Google Scholar 

  115. Sexton M, Jones DB, Maloney ME (1990) Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 23:1118–1126

    Article  PubMed  CAS  Google Scholar 

  116. Breuninger H, Dietz K (1991) Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 17:574–578

    PubMed  CAS  Google Scholar 

  117. Rowe DE, Carroll RJ, Day CL Jr (1989) Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15:424–431

    PubMed  CAS  Google Scholar 

  118. Chiller K, Passaro D, McCalmont T, Vin-Christian K (2000) Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer. Arch Dermatol 136:1327–1332

    Article  PubMed  CAS  Google Scholar 

  119. Jiang SB. Mohs Surgery. eMedicine Web Site. 5–4–2007. 3–2–2008

    Google Scholar 

  120. Wennberg AM, Larko O, Stenquist B (1999) Five-year results of Mohs ' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 79:370–372

    Article  PubMed  CAS  Google Scholar 

  121. Cook J, Zitelli JA (1998) Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39:698–703

    Article  PubMed  CAS  Google Scholar 

  122. Bath-Hextall F, Perkins W, Bong J, Williams H (2007) Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev CD003412

    Google Scholar 

  123. Cornell RC, Greenway HT, Tucker SB, Edwards L, Ashworth S, Vance JC, Tanner DJ, Taylor EL, Smiles KA, Peets EA (1990) Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 23:694–700

    Article  PubMed  CAS  Google Scholar 

  124. Vine JE (2001) Skin cancer update. Treatment alternatives for basal-cell and squamous-cell carcinoma. N J Med 98:35–37

    PubMed  CAS  Google Scholar 

  125. Ebner H (1970) Treatment of skin epitheliomas with 5-flu-orouracil (5-FU) ointment. Influence of therapeutic design on recurrence of lesions. Dermatologica 140:42–46

    Article  PubMed  Google Scholar 

  126. Epstein E (1985) Fluorouracil paste treatment of thin basal cell carcinomas. Arch Dermatol 121:207–213

    Article  PubMed  CAS  Google Scholar 

  127. Klostermann GF (1970) Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological find-ings and deep action. Dermatologica 140:47–54

    Article  PubMed  Google Scholar 

  128. Gross K, Kircik L, Kricorian G (2007) 5 % 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33:433–439

    Article  PubMed  CAS  Google Scholar 

  129. Cristofolini M, Zumiani G, Scappini P, Piscioli F (1984) Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol 10:778–781

    PubMed  CAS  Google Scholar 

  130. Hodak E, Ginzburg A, David M, Sandbank M (1987) Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect. Int J Dermatol 26:606–609

    Article  PubMed  CAS  Google Scholar 

  131. Peck GL (1986) Topical tretinoin in actinic keratosis and basal cell carcinoma. J Am Acad Dermatol 15:829–835

    Article  PubMed  CAS  Google Scholar 

  132. Peck GL, DiGiovanna JJ, Sarnoff DS, Gross EG, Butkus D, Olsen TG, Yoder FW (1988) Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 19:176–185

    Article  PubMed  CAS  Google Scholar 

  133. Stanley MA (2002) Imiquimod and the imidazoquinolo-nes: mechanism of action and therapeutic potential. Clin Exp Dermatol 27:571–577

    Article  PubMed  CAS  Google Scholar 

  134. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M (2004) Imiquimod 5 % cream for the treatment of super-ficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50:722–733

    Article  PubMed  Google Scholar 

  135. Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, Owens M (2002) Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47:390–398

    Article  PubMed  Google Scholar 

  136. Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia DA, Tebbs V, McRae S (2005) Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 152:939–947

    Article  PubMed  CAS  Google Scholar 

  137. Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, Andres K, Amies M, Owens M (2002) Efficacy of topical 5 % imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 138:1165–1171

    Article  PubMed  CAS  Google Scholar 

  138. Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Mohrle M, Radny P, Garbe C (2007) A phase III, randomized, open label study to evaluate the safety and effi-cacy of imiquimod 5 % cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 57:616–621

    Article  PubMed  Google Scholar 

  139. Wagstaff A, Perry C (2007) Topical Imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma, and other skin lesions. Adis Drug Evaluation 67:2187–2210

    CAS  Google Scholar 

  140. Neville JA, Williford PM, Jorizzo JL (2007) Pilot study using topical imiquimod 5 % cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. J Drugs Dermatol 6:910–914

    PubMed  Google Scholar 

  141. Rigel D, Torres A, Ely H (2006) Effectiveness of curettage and 5 % imiquimod cream in the treatment of basal cell carcinoma: clinical and cosmetic evaluation. J Am Acad Dermatol 54:AB174

    Article  Google Scholar 

  142. Spencer JM (2006) Pilot study of imiquimod 5 % cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Dermatol Surg 32:63–69

    Article  PubMed  CAS  Google Scholar 

  143. Guthrie TH Jr, Porubsky ES, Luxenberg MN, Shah KJ, Wurtz KL, Watson PR (1990) Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 8:342–346

    PubMed  Google Scholar 

  144. Coker DD, Elias EG, Viravathana T, McCrea E, Hafiz M (1983) Chemotherapy for metastatic basal cell carcinoma. Arch Dermatol 119:44–50

    Article  PubMed  CAS  Google Scholar 

  145. Hartman R, Hartman S, Green N (1986) Long-term survival following bony metastases from basal cell carcinoma. Report of a case. Arch Dermatol 122:912–914

    Article  PubMed  CAS  Google Scholar 

  146. Wieman TJ, Shively EH, Woodcock TM (1983) Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report. Cancer 52:1583–1585

    Article  PubMed  CAS  Google Scholar 

  147. Guthrie TH, Jr., McElveen LJ, Porubsky ES, Harmon JD (1985) Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer 55:1629–1632

    Article  PubMed  Google Scholar 

  148. Guthrie TH, Porubsky ES (1982) Successful systemic chemotherapy of advanced squamous and basal cell carcinoma of the skin with cis-diamminedichloroplatinum III and doxorubicin. Laryngoscope 92:1298–1299

    Article  PubMed  CAS  Google Scholar 

  149. Robinson JK (1987) Use of a combination of chemotherapy and radiation therapy in the management of advanced basal cell carcinoma of the head and neck. J Am Acad Dermatol 17:770–774

    Article  PubMed  CAS  Google Scholar 

  150. Marcil I, Stern RS (2000) Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of non-melanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136:1524–1530

    Article  PubMed  CAS  Google Scholar 

  151. Rowe DE, Carroll RJ, Day CL Jr (1989) Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15:315–328

    PubMed  CAS  Google Scholar 

  152. Marghoob A, Kopf AW, Bart RS, Sanfilippo L, Silverman MK, Lee P, Levy E, Vossaert KA, Yadav S, Abadir M (1993) Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 28:22–28

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Johns Hopkins School of Medicine, 601 N. Wolfe Street, Baltimore, MD, 21287, USA

    Manisha J Patel

Authors
  1. Manisha J Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phillip M Williford
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen Shumack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manisha J Patel .

Editor information

Editors and Affiliations

  1. Skin Cancer Center Charité, Department of Dermatology, Charité University Medicine Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Eggert Stockfleth

  2. Department of Dermatology, 6620 Main Street, Suite 1425, Houston, TX, 77030, USA

    Theodore Rosen (Chief of VA Dermatology Clinic Professor) (Chief of VA Dermatology Clinic Professor)

  3. Ground Floor, 225 Macquarie Street, Sydney, NSW, 2000, Australia

    Stephen Shumack

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Patel, M.J., Williford, P.M., Shumack, S. (2010). Basal Cell Carcinoma. In: Stockfleth, E., Rosen, T., Shumack, S. (eds) Managing Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79347-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79347-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79346-5

  • Online ISBN: 978-3-540-79347-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation